Detalhe da pesquisa
1.
Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors.
J Med Chem
; 58(16): 6348-58, 2015 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26181851